Pediatric anti-CaVα2δ autoimmune encephalitis: A case report and literature review

IF 2.9 4区 医学 Q3 IMMUNOLOGY
Min Zhang, Xiaomei Zhu, Lifei Yu, Zhixu Fang, Yi Wang, Linmei Zhang
{"title":"Pediatric anti-CaVα2δ autoimmune encephalitis: A case report and literature review","authors":"Min Zhang,&nbsp;Xiaomei Zhu,&nbsp;Lifei Yu,&nbsp;Zhixu Fang,&nbsp;Yi Wang,&nbsp;Linmei Zhang","doi":"10.1016/j.jneuroim.2025.578550","DOIUrl":null,"url":null,"abstract":"<div><div>Anti-voltage-gated calcium channel alpha-2/delta subunit (anti-CaVα2δ) encephalitis is a rare autoimmune encephalitis (AE), with only two cases of anti-CaVα2δ AE have been reported in the literatureto date. The clinical characteristics and prognosis of this rare AE need to beexpanded.We present the case of a 9-year-oldgirl, who initially presented with fever and lymphadenitis, which progressed to headaches, drowsiness, frequent seizures, cognitive impairment, memory loss, and involuntary movements. Brain magnetic resonance imaging revealed lesions in the bilateral external capsule. Moreover, anti-CaVα2δ antibodies were detected (1,30) 3 and 5 weeks after symptom onset. Video electroencephalography revealed slow, severely diffuse, background activity with multifocal epileptiform discharges. Although the patient was administered a combined immunotherapy consisting of intravenous immunoglobulin, intravenous methylprednisolone, and rituximab, sheexhibited persistent neurological sequelae at the last follow-up (Modified Rankin Scale score of 4; Pediatric Quality of Life Inventory score of 75). Whileour case shares similar clinical characteristics with previously reported anti-CaVα2δ AE cases, our patientwas unresponsive to immunotherapy and experienced severe neurological sequelae during follow-up. This report broadens the clinical phenotype and prognosis associated with this rare condition, providing further information and clinical insights for the management of future cases.</div></div>","PeriodicalId":16671,"journal":{"name":"Journal of neuroimmunology","volume":"401 ","pages":"Article 578550"},"PeriodicalIF":2.9000,"publicationDate":"2025-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neuroimmunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S016557282500030X","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Anti-voltage-gated calcium channel alpha-2/delta subunit (anti-CaVα2δ) encephalitis is a rare autoimmune encephalitis (AE), with only two cases of anti-CaVα2δ AE have been reported in the literatureto date. The clinical characteristics and prognosis of this rare AE need to beexpanded.We present the case of a 9-year-oldgirl, who initially presented with fever and lymphadenitis, which progressed to headaches, drowsiness, frequent seizures, cognitive impairment, memory loss, and involuntary movements. Brain magnetic resonance imaging revealed lesions in the bilateral external capsule. Moreover, anti-CaVα2δ antibodies were detected (1,30) 3 and 5 weeks after symptom onset. Video electroencephalography revealed slow, severely diffuse, background activity with multifocal epileptiform discharges. Although the patient was administered a combined immunotherapy consisting of intravenous immunoglobulin, intravenous methylprednisolone, and rituximab, sheexhibited persistent neurological sequelae at the last follow-up (Modified Rankin Scale score of 4; Pediatric Quality of Life Inventory score of 75). Whileour case shares similar clinical characteristics with previously reported anti-CaVα2δ AE cases, our patientwas unresponsive to immunotherapy and experienced severe neurological sequelae during follow-up. This report broadens the clinical phenotype and prognosis associated with this rare condition, providing further information and clinical insights for the management of future cases.
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of neuroimmunology
Journal of neuroimmunology 医学-免疫学
CiteScore
6.10
自引率
3.00%
发文量
154
审稿时长
37 days
期刊介绍: The Journal of Neuroimmunology affords a forum for the publication of works applying immunologic methodology to the furtherance of the neurological sciences. Studies on all branches of the neurosciences, particularly fundamental and applied neurobiology, neurology, neuropathology, neurochemistry, neurovirology, neuroendocrinology, neuromuscular research, neuropharmacology and psychology, which involve either immunologic methodology (e.g. immunocytochemistry) or fundamental immunology (e.g. antibody and lymphocyte assays), are considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信